Research Article
Relation of Wnt Signaling Pathway Inhibitors (Sclerostin and Dickkopf-1) to Left Ventricular Mass Index in Maintenance Hemodialysis Patients
Table 3
Comparative analysis of some laboratory data among the studied two subgroups.
| | Parameter | Subgroup 1 | Subgroup 2 | value |
| | HB (gm/dl) | 10.096 ± 1.43 | 8.92 ± 1.633 | 0.006 | | Iron (µg/dl) | 82.5 (36.00–202) | 72 (35.00–222) | 0.087 | | TSAT% | 38 (13.00–85.00) | 32 (17.00–91.00) | 0.111 | | TIBC | 225.83 ± 36.58 | 221.08 ± 45.195 | 0.668 | | S. albumin (gm/dl) | 3.85 ± .295 | 3.64 ± .498 | 0.066 | | Alk_phosph (IU/L) | 131 (11.00–2152) | 168 (64.00–1003) | 0.209 | | S. chol. (mg/dl) | 162 (93.0–243) | 130 (79.0–375) | 0.140 | | S. TG (mg/dl) | 135.5 (48.0–232) | 112 (45.0–276) | 0.438 | | S. HDL (mg/dl) | 25 (16.0–63.0) | 23 (11.0–56.0) | 0.169 | | S. LDL (mg/dl) | 104 (29.8–159.8) | 87.4 (39.8–332.2) | 0.232 | | Kt/V | 1.12 ± .34 | 1.13 ± .23 | 0.877 | | S. Ca (mg/dl) | 8.47 ± .976 | 8.19 ± .89 | 0.250 | | S. PO4 (mg/dl) | 4.92 ± 1.45 | 4.95 ± 1.69 | 0.945 | | iPTH (pg/ml) | 648 (10.60–1900) | 576 (27.00–2000) | 0.790 | | Sclerostin (ng/ml) | 35.25 (3.40–59.3) | 7.70 (2.10–60.4) | 0.013 | | Dkk-1 (pg/ml) | 63 (12.00–132) | 33 (13.00–112) | 0.011 |
|
|
Significant at . Highly significant at . HB: hemoglobin; gm/dl: gram/deciliter; µg/dl: microgram/deciliter; TSAT: transferrin saturation, Alk_phosph: alkaline phosphatase; IU/L: international unit/liter; S. chol.: serum cholesterol; S. TG: serum triglycerides; S. HDL: serum high-density lipoprotein; S. LDL: serum low-density lipoprotein; Kt/V: kinetic time/volume; S. Ca: serum calcium; S. PO 4: serum phosphorus; iPTH: intact parathyroid hormone; pg/ml: picogram/milliliter; ng/ml: nanogram/milliliter. |
